Delivery Order SPE2DB25D3003-SPE2DB25FPVYJ

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a ceiling value of $7,710.65 and a period of performance through March 5, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a ceiling value of $2,014.57 and a period of performance through June 18, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a prescription medication, with a ceiling value of $4,772.54 and a completion date of February 21, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a prescription medication, with a ceiling value of $4,374.77 and a completion date of December 6, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The award has a ceiling value of $4,789.56 and an ultimate completion date of February 3, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, valued at $2,905.23, with a completion date of January 2, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a medical product, with a ceiling value of $1,510.60 and an ultimate completion date of March 10, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a ceiling value of $9,418.68 and a period of performance through October 26, 2023. The award is a delivery order against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a ceiling value of $17,027.64 and an ultimate completion date of May 24, 2024. It is a delivery order contract with a firm fixed price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS medication. The contract has a ceiling value of $5,772.15 and runs through February 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC...
  • SPE2DB25D3003
    Indefinite Delivery Contract
  • SPE2DB25D3003-SPE2DB25FPVYJ
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a ceiling value of $4,455.55 and runs through March 11, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 6/9/25, 9:59 AM